Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
659.43B
Market cap659.43B
Price-Earnings ratio
42.28
Price-Earnings ratio42.28
Dividend yield
1.89%
Dividend yield1.89%
Average volume
8.01M
Average volume8.01M
High today
$278.70
High today$278.70
Low today
$273.88
Low today$273.88
Open price
$275.55
Open price$275.55
Volume
2.75M
Volume2.75M
52 Week high
$290.25
52 Week high$290.25
52 Week low
$198.53
52 Week low$198.53

Stock Snapshot

With a market cap of 659.43B, Johnson & Johnson(JNJ) trades at $273.93. The stock has a price-to-earnings ratio of 42.28 and currently yields dividends of 1.89%.

On 2026-11-18, Johnson & Johnson(JNJ) stock traded between a low of $273.88 and a high of $278.70. Shares are currently priced at $273.93, which is +0.0% above the low and -1.7% below the high.

Johnson & Johnson(JNJ) shares are trading with a volume of 2.75M, against a daily average of 8.01M.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $290.25 and a 52-week low of $198.53.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $290.25 and a 52-week low of $198.53.

JNJ News

24/7 Wall St. 3h
Invest $25,000 in These 4 Dividend Stocks to Start Building Retirement Income

It sounds nuts, but SoFi is giving new Active Invest users up to $1,000 in stock for a limited time, and all it takes is a $50 deposit to get started. See for y...

Invest $25,000 in These 4 Dividend Stocks to Start Building Retirement Income
New York Times 4h
JJ Gabriel visits Real Madrid training ground ahead of expected move from Manchester United - The New York Times

...

JJ Gabriel visits Real Madrid training ground ahead of expected move from Manchester United - The New York Times
TipRanks 17h
Johnson & Johnson price target raised to $292 from $275 at BofA

BofA raised the firm’s price target on Johnson & Johnson to $292 from $275 and keeps a Neutral rating on the shares. The company enters its December 8th Enterp...

Analyst ratings

67%

of 27 ratings
Buy
66.7%
Hold
25.9%
Sell
7.4%

More JNJ News

The Motley Fool 20h
Johnson & Johnson vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy for 2027?

Healthcare investors often choose between established stability and high-growth innovation. Determining whether Johnson & Johnson (JNJ -1.36%) or Vertex Pharmac...

Johnson & Johnson vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy for 2027?
The Motley Fool 1d
Johnson & Johnson vs. Pfizer: Consistency vs. Volatility in Revenue

Johnson & Johnson: Steady Upward Recent Revenue Growth Johnson & Johnson (JNJ -0.97%) primarily generates revenue by developing and selling pharmaceutical and m...

Johnson & Johnson vs. Pfizer: Consistency vs. Volatility in Revenue
Simply Wall St 1d
Is Johnson & Johnson Fully Valued Following Its Reported Ollin Biosciences Talks?

Johnson & Johnson (JNJ) is back in focus after reports that it is negotiating a potential Ollin Biosciences acquisition valued at up to US$3.4b, a move watched...

Is Johnson & Johnson Fully Valued Following Its Reported Ollin Biosciences Talks?
Zacks 1d
Here is What to Know Beyond Why Johnson & Johnson is a Trending Stock

Johnson & Johnson (JNJ Quick QuoteJNJ - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some...

Here is What to Know Beyond Why Johnson & Johnson is a Trending Stock
The Motley Fool 1d
Johnson & Johnson vs. Novo Nordisk: Steady Uptrend vs. Flat Revenue

Johnson & Johnson: A Steady Revenue Uptrend Johnson & Johnson (JNJ -1.12%) primarily generates revenue by developing and selling pharmaceutical treatments and m...

Johnson & Johnson vs. Novo Nordisk: Steady Uptrend vs. Flat Revenue
Benzinga 2d
Johnson & Johnson Inks $2.2B Deal for Eye Drug Developer Ollin Biosciences

Johnson & Johnson (NYSE:JNJ) on Monday agreed to acquire Ollin Biosciences, a clinical-stage biopharmaceutical company focused on therapies for serious eye dise...

Johnson & Johnson Inks $2.2B Deal for Eye Drug Developer Ollin Biosciences
24/7 Wall St. 2d
Treasury Yields Just Hit 4.88%, Changing the Math for Dividend Investors

It sounds nuts, but SoFi is giving new Active Invest users up to $1,000 in stock for a limited time, and all it takes is a $50 deposit to get started. See for y...

Treasury Yields Just Hit 4.88%, Changing the Math for Dividend Investors

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.